Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus

@article{Srivastava2020EfficacyTA,
  title={Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus},
  author={K. Srivastava and S. Bhartiya and Vrushabh Gavli and R. Patil and S. Rajadhyaksha},
  journal={Indian Pediatrics},
  year={2020},
  volume={57},
  pages={218-221}
}
Objective To evaluate the efficacy and tolerability of intravenous fosphenytoin in children with status epilepticus, and resulting serum total phenytoin levels. Methods In this prospective study, 51 children aged less than 18 years received intravenous loading dose of fosphenytoin (18-20 mg/kg). Serum total phenytoin levels were estimated at 90 -100 minutes. Outcomes studied were ( i ) seizure control and local and/ or systemic adverse effects in next 24 hours and ( ii ) phenytoin levels and… Expand

Figures, Tables, and Topics from this paper

Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management
TLDR
There is a lack of robust published data regarding the safety and effectiveness of various therapies, and there continues to be a need for large randomized multicenter trials comparing newer therapies to treat this refractory condition. Expand
Fosphenytoin in Status Epilepticus: The Ice Needs to be Broken
Status epilepticus (SE) is the most common neurological emergency encountered by pediatricians and the incidence is significantly higher in children compared to adults. North London StatusExpand
Childhood Status Epilepticus: Current Status and Future Directions
TLDR
Given the lack of information on etiology and outcome of SE in children from India, the study by Chetan, et al. in this issue of Indian Pediatrics is a welcome addition to the literature on the topic. Expand

References

SHOWING 1-10 OF 27 REFERENCES
Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
TLDR
The inadequate control of status epilepticus despite rapid achievement of therapeutic unbound phenytoin concentrations warrants further investigation, and administration of fosphenytoin i.m. offers a practical and convenient alternative to i.v. pheny toin. Expand
Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage
TLDR
Rapid intravenous loading of fosphenytoin was well tolerated and effective in promptly achieving the therapeutic level of free Phenytoin, but most patients experienced overshoot of free pheny toin at the end of infusion. Expand
Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting
TLDR
Close laboratory surveillance and PHT/FOS dose adjustments are recommended to ensure adequate and sustained tPHT serum levels early in treatment. Expand
The safety and efficacy of fosphenytoin for the treatment of status epilepticus
TLDR
The main indications for fosphenytoin are the treatment of convulsive status epilepticus and the prevention/management of seizures during neurosurgery and avoiding complications associated with parenteral use of phenytoin. Expand
Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers
TLDR
The pharmacokinetic parameters of phenytoin, such as total clearance and central and peripheral volume of distribution were influenced by body weight, and the administration of fosphenytoin sodium 22.5 mg/kg at an infusion rate of 3  mg/kg/min was optimal for achieving the desired plasma pheny toin concentration. Expand
Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
TLDR
The pharmacokinetic properties of fosphenytoin permit the drug to serve as a well tolerated and effective alternative to parenteral phenytoin in the emergency and non-emergency management of acute seizures in children and adults. Expand
Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population*
TLDR
Concomitant phenobarbital use may increase clearance of phenytoin and fosphenytoin dose reductions should occur in patients with reduced kidney function, and a loading dose of 20 mg/kg followed by 6  mg/kg/dose every 8 hours is a reasonable empiric strategy for attainment and maintenance of therapeutic trough concentrations. Expand
Fosphenytoin vs. continuous midazolam for pediatric febrile status epilepticus
TLDR
The results suggest that fPHT is relatively safe as a second-line treatment for pediatric SE in patients who do not require BCT, although cMDL may prevent the need for BCT compared with fP HT. Expand
Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients
TLDR
Contrary to the adult population, loading dose adjustments do not seem to be required in pediatric patients after intravenous bolus fosphenytoin administration, and obesity does not affect serum phenytoin concentrations. Expand
Therapeutic Drug Monitoring of Phenytoin in Critically Ill Patients
TLDR
Free serum concentrations should be measured, or theoretically calculated if measurements are unavailable, to avoid misinterpretation of total serum levels and consequent inappropriate adjustments in the dosage of phenytoin in critically ill patients. Expand
...
1
2
3
...